为攻克胰腺导管腺癌（PDAC）难题，研究人员聚焦于IL-33激活的ILC2诱导三级淋巴结构（TLS）形成机制，揭示其抗癌免疫潜力，为免疫治疗提供新思路，具有重要意义。 胰腺导管腺癌（PDAC）是一种恶性程度极高、预后极差的癌症，其免疫治疗一直面临巨大挑战。

"Given the importance of ILC2s in allergic asthma, there is an urgent need to ... suggest a significant role for Piezo1 channels in ILC2 metabolism, as treatment with Yoda1 reduced ILC2 ...

"Given the importance of ILC2s in allergic asthma, there is an urgent need to ... Yoda1 may be used as a therapeutic tool to modulate ILC2 function and alleviate the symptoms associated with ...